Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer

ClinicalTrials.gov ID: NCT00350948

Public ClinicalTrials.gov record NCT00350948. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 1, 2026, 8:50 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3 Randomized Study of TLK286 (Telcyta®) in Combination With Liposomal Doxorubicin (Doxil/Caelyx)Versus Liposomal Doxorubicin (Doxil/Caelyx) as Second-Line Therapy in Platinum Refractory or Resistant Ovarian Cancer (ASSIST-5)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this research study is to determine if Telcyta® given in combination with liposomal doxorubicin is more effective than liposomal doxorubicin alone in treating women who have recurrent ovarian epithelial cancer, fallopian tube cancer or primary peritoneal cancer that is refractory or resistant to platinum chemotherapy.

Study identification

NCT ID
NCT00350948
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Telik
Industry
Enrollment
244 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2006 (Type not available)
Primary completion
Dec 2008 (Actual)
Completion
Dec 2008 (Actual)
Last update posted
Nov 27, 2013

2006 – 2008

United States locations

U.S. sites
63
U.S. states
22
U.S. cities
52
Facility City State ZIP Site status
Desert Oasis Cancer Center Casa Grande Arizona 85222 —
Hematology Oncology Services of Arkansas Little Rock Arkansas 72205 —
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 —
East Bay Medical Oncology/Hematology Medical Associates, Inc. Antioch California 94509 —
Bay Area Cancer Research Group, LLC Concord California 94520 —
East Bay Medical Oncology/Hematology Medical Associates Concord California 94520 —
California Oncology of the Central Valley Fresno California 93710 —
Women's Cancer Research Foundation Newport Beach California 92663 —
Southwest Cancer Care Poway California 92064 —
Desert Hematology Oncology Medical Group Rancho Mirage California 92270 —
Southern California Permanente Medical Group San Diego California 92120 —
East Bay Medical Oncoogy/Hematology Medical Associates, Inc. San Leandro California 94578 —
Diablo Valley Oncology & Hematology Medical Group, Inc. Walnut Creek California 94598 —
Gynecologic Oncology Associates, Inc Hollywood Florida 33020 —
Shands Jacksonville Medical Center Jacksonville Florida 32209 —
University of Florida College of Medicine-Jacksonville Jacksonville Florida 32209 —
Florida Hospital Cancer Institute Orlando Florida 32804 —
Florida Hospital Orlando Florida 32804 —
Gynecologic Oncology Associates, Inc Pembroke Pines Florida 33028 —
Memorial Health University Medical Center Savannah Georgia 31404 —
Kaiser Permanente Moanalua Medical Center Honolulu Hawaii 96819 —
Flossmoor Cancer Care (JOHA DBA) Flossmoor Illinois 60422 —
Joliet Oncology-Hematology Associates Joliet Illinois 60432 —
Joliet Oncology-Hematology Associates, LTD. Joliet Illinois 60435 —
Kankakee Cancer Center (JOHA DBA) Kankakee Illinois 60901 —
Joliet Oncology-Hematology Associates Morris Illinois 60450 —
St. Vincent Gynecologic Oncology Indianapolis Indiana 46260 —
Central Baptist Hospital Lexington Kentucky 40503 —
Hematology and Oncology Specialists, LLC Metairie Louisiana 70006 —
LSU Health Sciences Center Shreveport Louisiana 71103 —
Center for Cancer and Blood Disorders Bethesda Maryland 20817 —
Arch Medical Services St Louis Missouri 63141 —
Hematology & Oncology Consultants P.C. Omaha Nebraska 68122 —
Horizon's West Medical Group Scottsbluff Nebraska 69361 —
The Women's Center of Western Nebraska Scottsbluff Nebraska 69361 —
Schwaartz Gynecologic Oncology, PLLC Babylon New York 11702 —
The Mary Imogene Bassett Hospital Cooperstown New York 13326 —
Monter Cancer Center Lake Success New York 11042 —
North Shore University Hospital Manhasset New York 11030 —
Long Island Jewish Medical Center New Hyde Park New York 11040 —
Hope A Women's Cancer Center Asheville North Carolina 28816 —
Blumenthal Cancer Center Charlotte North Carolina 28204 —
Carolinas Medical Center Charlotte North Carolina 28204 —
Presbyterian Hospital Charlotte North Carolina 28204 —
Piedmont Hematology Oncology Associates-Lexington Satellite Lexington North Carolina 27292 —
Piedmont Hematology Oncology Associates Winston-Salem North Carolina 27103 —
Dakota Cancer Institute/Dakota Clinic Ltd. Fargo North Dakota 58103 —
Gynecologic Oncology & Pelvic Surgery Associates Columbus Ohio 43222 —
Garth Phibbs, M.D., FACOG Toledo Ohio 43606 —
The Toledo Hospital Toledo Ohio 43606 —
Kaiser Permanente NW, Oncology/Hematology Portland Oregon 97227 —
Oregon Health & Science University Portland Oregon 97239-3098 —
Abington Memorial Hospital Abington Pennsylvania 19001 —
Hematology & Oncology Associates of NEPA Dunmore Pennsylvania 18512 —
Magee Women's Hospital of UPMC Pittsburgh Pennsylvania 15213 —
Associates in Hematolog-Oncology, P.C. Upland Pennsylvania 19013 —
Carolina Center of Gynecologic Oncology Charleston South Carolina 29407 —
Palmetto Health Alliance-Richland Columbia South Carolina 29210 —
South Carolina Oncology Associates Columbia South Carolina 29210 —
Arlington Cancer Center Arlington Texas 76012 —
Arlington Cancer Center Trophy Club Texas 76262 —
Danville Hematology & Oncology, Inc. Danville Virginia 24541 —
Carilion GYN Oncology Associates Roanoke Virginia 24014 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00350948, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 27, 2013 · Synced Nov 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00350948 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →